Ask a room of injectors how they would know they had caused an occlusion and the first answer, almost always, is pain out of proportion. It is the right instinct and it is a genuinely useful sign. It is also the sign most likely to be absent in exactly the situation where you most need it, because vascular occlusion pain is a nociceptive signal, and a large part of what we do before injecting is dedicated to abolishing nociceptive signals.
Pain helps. Pain is not 100%. Do not rely on a patient's report of pain to tell you whether you have a true occlusion — and never treat its absence as reassurance.
The mechanism: why ischemia hurts, and what we do to that
Ischemic pain is produced by tissue that is not receiving oxygen. Anaerobic metabolism, local acidosis and accumulating metabolites sensitize and activate nociceptors, and the resulting signal travels up small-diameter afferents — the same fibers that carry the pain of the injection itself.
This is the problem in a sentence. The final common pathway for ischemic pain and for procedural pain is identical. Anything that blocks the procedural pain blocks the ischemic pain with it. We are not selectively removing the sensation we find inconvenient; we are removing an entire afferent channel, and one of the things transmitted on that channel is the alarm.
Three interventions do this routinely:
Regional nerve blocks. An infraorbital block anesthetizes the upper lip, lateral nose and medial cheek. A mental block anesthetizes the lower lip and chin. Both typically outlast the appointment by hours. A patient who has had bilateral blocks for a lip treatment has a densely anesthetized perioral region for the entire early window in which an occlusion would be expected to declare itself by pain.
Lidocaine within the product. Most contemporary hyaluronic acid fillers are supplied with lidocaine. The concentration is low and the intent is comfort, but it is delivered directly into the tissue you are worried about, and it takes effect where the product sits — which is precisely the territory at risk.
Topicals, ice and vibration. Topical anesthetic reduces cutaneous sensation. Ice does the same and adds a second problem: it produces vasoconstriction, cools the skin and blanches it, degrading three of the visual and tactile findings you would otherwise use. Vibration and distraction devices work by gate control and raise the threshold for reporting discomfort.
None of these are errors. Comfort is part of competent practice and patients should not be asked to endure avoidable pain as a diagnostic convenience. The error is failing to account for what you have done to your own monitoring.
Where it fails worst: the lips
The perioral region is the confluence of every factor that degrades pain as a sign.
It is the region most likely to be blocked, because it is the region least tolerable without a block. It is highly vascular, with the superior and inferior labial arteries running in a plane injectors work in daily and with well-described variability in depth and course. It swells more than anywhere else, which obscures the contour and color changes you would otherwise notice. And it is the region where patients most expect to feel odd afterwards, so early symptoms get normalized by both parties.
Put those together and the lip is where the classical presentation is most likely to be silent. I tell injectors plainly: in the lips, especially when you have blocked, do not expect pain to announce the problem. You may or may not see the reticular rash. You may or may not see blanching. What you must do is look, deliberately, for findings that do not depend on the patient's report. Our wider discussion of common lip filler reactions sets out the range of expected findings in this region, which is the baseline you are comparing against.
What replaces pain when pain is unavailable
If you have anesthetized the territory, your assessment has to shift from what the patient reports to what you can observe and measure. Four findings carry the load.
Color. Dusky, mottled, gray or violaceous change — and in some presentations, pallor. Color is available to you when pain is not, and it is the finding most likely to be there in place of the symptom you have abolished. It is also comparative: scan the treated territory against its contralateral match rather than judging a patch on its own.
Capillary refill. Press and release, and compare against the immediately surrounding skin and the matched contralateral site. Delayed refill in an anesthetized field is a perfusion finding that no amount of lidocaine can suppress.
Temperature. The back of your fingers against the treated site and against its mirror image. Tissue that is cooler than its contralateral match, in close proximity, in a patient who has just been injected, is a blood flow problem until proven otherwise.
Territory, not entry point. Scan the whole vascular territory of the region you treated, not just where the needle went in. Skin changes appear away from the injection site, which is why an assessment confined to the puncture mark finds nothing.
None of these require the patient to feel anything. That is the entire reason they are the backbone of the assessment.
Sequencing the appointment around the anesthesia
If anesthesia degrades your monitoring, the sequence of the appointment becomes a safety variable. Four adjustments are worth making.
Assess before you add more. Perform a perfusion check between stages rather than only at the end. The first pass in an un-blocked or minimally blocked field is the one in which the patient's report is still worth something; after that, you are increasingly on your own.
Ready to put this into practice?
Explore Empire's hands-on, CME-accredited Aesthetic & Injectable Training courses — live patients, expert faculty, and ongoing mentorship.
Think about ice deliberately. Ice suppresses sensation, constricts vessels, cools the skin and blanches it — four of the findings you would otherwise use, degraded simultaneously. That is not an argument against using it. It is an argument for knowing when it was last applied and for not reading a perfusion assessment through it.
Assess again after the block has begun to wear off. If the treatment ran in a densely anesthetized field, the returning sensation is diagnostic information arriving late. A scheduled contact timed to roughly when the block should be resolving asks the patient a question they can finally answer.
Write the anesthesia into the record as a monitoring note, not just a drug entry. The next clinician to assess this patient — which may be you at hour four, or a colleague covering the evening — needs to know that the pain channel was offline and by what.
The reverse failure: over-reading pain
There is a mirror-image error worth naming, because the rest of this piece can be misread as "pain is unimportant."
Pain that is present and escalating is one of the most useful signals you have. Pain that is disproportionate to the procedure you performed — a lip treatment that hurts like a fracture, a cheek that is still worsening at hour six — should stop you regardless of how good the aesthetic result looks. The trap is the patient who says something does not feel right and is told that swelling is normal. Move the ego out of these situations and listen to the patient. Then react.
The asymmetry is the thing to hold: pain present and escalating is highly informative. Pain absent is not informative at all, because you may have removed it yourself.
What to do differently on Monday
Chart the anesthesia as a monitoring variable. Write down which blocks you placed, which agent, and when. That note tells the person assessing this patient at hour three — possibly you, possibly a colleague — that the pain channel is offline and the assessment must be visual and tactile.
Run the perfusion check at fixed points, not on symptoms. If pain is your trigger and pain is blocked, you have no trigger. Build in scheduled checks: before the patient sits up, before they leave, and at the follow-up contact.
Set home instructions that do not depend on pain. Tell an anesthetized patient what to look at rather than what to feel — color, blotchiness, a patch that looks different from the rest — and tell them the block will wear off and that new or escalating pain after it does is a reason to call, not a reason to take an analgesic and wait.
Treat any visual symptom as its own category. Blurred vision, visual field change or ocular pain is never a watch-and-wait, whether or not there is facial pain and whether or not the face looks normal. That is an immediate escalation, with the patient accompanied to an emergency department, ideally one with interventional radiology available, and with you speaking directly to the emergency physician about exactly what was injected. The mechanism behind ophthalmic artery involvement is covered in our piece on whether injectables can cause blindness.
Lower your threshold for acting on suspicion. Act on suspicion rather than waiting for full-blown ischemia. In a blocked field, suspicion may be all you are going to get. Knowing how and when to dissolve filler is what makes acting early a low-cost decision rather than a high-stakes one.
This reflects Michelle Langston's clinical practice as taught in Empire Medical Training's hands-on curriculum. Technique is learned under supervision; this article is educational and is not a substitute for training.
Comfort and safety are not in conflict here — but they are coupled, and the coupling has to be deliberate. If you are going to take the pain signal away from your patient, you have to give the monitoring back to yourself. That trade is learned at the chairside, under supervision, which is the setting Empire's Complete Dermal Filler Training is built around.
Frequently Asked Questions
Does a nerve block hide vascular occlusion?
It can hide the pain of one. Infraorbital and mental blocks anesthetize the perioral region for hours, and ischemic pain travels on the same afferent pathway as procedural pain, so the block suppresses both. The visual and tactile findings — color change, delayed capillary refill, temperature asymmetry — are unaffected and become the primary assessment.
Does pain-free mean there is no occlusion?
No. Absence of pain has very little negative predictive value, particularly in an anesthetized field or where the filler contains lidocaine. Occlusion is diagnosed on perfusion findings and pattern, not on patient comfort. Treat a normal pain report as uninformative rather than reassuring.
Should injectors stop using nerve blocks to preserve the pain signal?
No. Withholding appropriate anesthesia is not a reasonable safety strategy, and unrelieved procedural pain generates its own problems. The correct response is to document the block, recognize that pain-based monitoring is offline, and substitute scheduled perfusion checks and visual assessment for the missing signal.
Why are the lips the highest-risk region for a missed occlusion?
The lips combine dense regional anesthesia, a highly vascular bed with labial arteries in the working plane, pronounced expected swelling that obscures color and contour, and patient expectations that normalize odd sensations. Every factor that degrades the pain signal is present at once, so lip assessment must rely on observation rather than report.
Disclaimer
This article reflects the clinical opinions and experience of Michelle Langston, APRN, MSN, FNP-BC, an independent faculty member contributing to Empire Medical Training's curriculum. The views expressed are the author's own and do not necessarily represent those of Empire Medical Training.
It is professional education, not medical advice, and is no substitute for hands-on training or independent clinical judgment. Licensed clinicians remain responsible for their own patient selection, technique and outcomes, for verifying current product labelling, and for practising within their scope and applicable law. Empire Medical Training accepts no liability for reliance on this content.
